Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment
Led by Blue Venture Fund, new funding will accelerate Ultromics' use of AI-enabled echocardiograms to improve patient outcomes
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Aug 21
Led by Blue Venture Fund, new funding will accelerate Ultromics' use of AI-enabled echocardiograms to improve patient outcomes
16 Aug 21
The new Covid-19 test is designed to detect and differentiate all the new mutating Covid-19 variants
16 Aug 21
Omnipod is claimed to be the only insulin pump cleared for use with Lyumjev in the US
16 Aug 21
The researchers have identified a new approach to treat diseases that are characterised by inflammation and pain, including…
16 Aug 21
The physical event will be complemented with the Formnext Digital Days two weeks later from 30 November –…
16 Aug 21
FDA-cleared Caption AI will be exclusively combined with Butterfly’s hardware and software solution to pave the way for…
16 Aug 21
The cyclic motion of the heart applied to the device model gives unique insights into possible migration of…
16 Aug 21
This brand-new power assist technology was developed for our high-end radiographic system allowing it to operate smoothly and…
13 Aug 21
GWave is claimed to be the world's first non-invasive continuous glucose monitoring technology that uses RF waves to…
13 Aug 21
The new module will facilitate automated intra-operative assessments in real-time of the true location and positioning of the…